NeoGenomics, Inc. (NEO)

USD 9.38

(5.39%)

Inventory Summary of NeoGenomics, Inc.

  • NeoGenomics, Inc.'s latest annual inventory in 2023 was 24.15 Million USD , down -0.5% from previous year.
  • NeoGenomics, Inc.'s latest quarterly inventory in 2024 Q2 was 23.21 Million USD , up 14.24% from previous quarter.
  • NeoGenomics, Inc. reported annual inventory of 24.27 Million USD in 2022, up 3.77% from previous year.
  • NeoGenomics, Inc. reported annual inventory of 23.39 Million USD in 2021, down -20.76% from previous year.
  • NeoGenomics, Inc. reported quarterly inventory of 24.45 Million USD for 2024 Q3, up 5.35% from previous quarter.
  • NeoGenomics, Inc. reported quarterly inventory of 23.21 Million USD for 2024 Q2, up 14.24% from previous quarter.

Annual Inventory Chart of NeoGenomics, Inc. (2023 - 2000)

Historical Annual Inventory of NeoGenomics, Inc. (2023 - 2000)

Year Inventory Inventory Growth
2023 24.15 Million USD -0.5%
2022 24.27 Million USD 3.77%
2021 23.39 Million USD -20.76%
2020 29.52 Million USD 104.97%
2019 14.4 Million USD 66.53%
2018 8.65 Million USD 15.73%
2017 7.47 Million USD 19.53%
2016 6.25 Million USD 22.42%
2015 5.1 Million USD 95.26%
2014 2.61 Million USD 13.69%
2013 2.3 Million USD 23.78%
2012 1.85 Million USD 54.66%
2011 1.2 Million USD 35.51%
2010 887 Thousand USD 47.39%
2009 601.8 Thousand USD 22.45%
2008 491.45 Thousand USD 61.27%
2007 304.75 Thousand USD 159.67%
2006 117.36 Thousand USD 95.6%
2005 60 Thousand USD 296.77%
2004 15.12 Thousand USD 42.75%
2003 10.59 Thousand USD -45.13%
2002 19.3 Thousand USD 0.0%
2001 - USD 0.0%
2000 - USD 0.0%

Peer Inventory Comparison of NeoGenomics, Inc.

Name Inventory Inventory Difference
Aclaris Therapeutics, Inc. - USD -Infinity%
Applied DNA Sciences, Inc. 330.02 Thousand USD -7219.401%
Aspira Women's Health Inc. 227 Thousand USD -10541.41%
Biodesix, Inc. 1.4 Million USD -1625.429%
BioNexus Gene Lab Corp. 1.13 Million USD -2023.1%
bioAffinity Technologies, Inc. 18.48 Thousand USD -130585.999%
bioAffinity Technologies, Inc. 18.48 Thousand USD -130585.999%
Bionano Genomics, Inc. 22.89 Million USD -5.517%
CareDx, Inc 19.47 Million USD -24.061%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 7.94 Million USD -204.155%
DarioHealth Corp. 5.06 Million USD -377.203%
Exact Sciences Corporation 127.47 Million USD 81.05%
Fulgent Genetics, Inc. 5.82 Million USD -314.553%
Guardant Health, Inc. 61.94 Million USD 61.006%
ICON Public Limited Company 1.00 USD -2415599900.0%
IDEXX Laboratories, Inc. 380.28 Million USD 93.648%
Illumina, Inc. 587 Million USD 95.885%
Intelligent Bio Solutions Inc. 777.53 Thousand USD -3006.733%
iSpecimen Inc. - USD -Infinity%
Standard BioTools Inc. 20.53 Million USD -17.645%
MDxHealth SA 2.77 Million USD -769.234%
23andMe Holding Co. 12.46 Million USD -93.791%
Medpace Holdings, Inc. 1.00 USD -2415599900.0%
Myriad Genetics, Inc. 20.1 Million USD -20.179%
Mainz Biomed B.V. 613.63 Thousand USD -3836.523%
ENDRA Life Sciences Inc. 2.62 Million USD -820.978%
Neogen Corporation 189.26 Million USD 87.237%
Inotiv, Inc. 56.1 Million USD 56.943%
Natera, Inc. 40.75 Million USD 40.735%
OpGen, Inc. 1.00 USD -2415599900.0%
OPKO Health, Inc. 65.69 Million USD 63.231%
Psychemedics Corporation 1.00 USD -2415599900.0%
Prenetics Global Limited 3.12 Million USD -672.553%
Prenetics Global Limited 3.12 Million USD -672.553%
Precipio, Inc. 384 Thousand USD -6190.625%
Personalis, Inc. 5.66 Million USD -326.709%
RadNet, Inc. 1.00 USD -2415599900.0%
Sera Prognostics, Inc. - USD -Infinity%
Sotera Health Company 51.98 Million USD 53.533%
Neuronetics, Inc. 8.09 Million USD -198.48%
Star Equity Holdings, Inc. 3.42 Million USD -606.316%
Star Equity Holdings, Inc. 3.42 Million USD -606.316%
Trinity Biotech plc 19.93 Million USD -21.186%
T2 Biosystems, Inc. 4.81 Million USD -401.266%
Twist Bioscience Corporation 32.06 Million USD 24.661%
Exagen Inc. 2.87 Million USD -741.379%